VANCOmycin HCI PF — Class III drug recall D-0072-2024
Terminated recall by Denver Solutions, LLC DBA Leiters Health, reported 2023-11-01, distributed nationwide. Labeling: Not Elsewhere Classified
| Recall number | D-0072-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Denver Solutions, LLC DBA Leiters Health, Englewood, CO, United States |
| Recall initiated | 2023-10-04 |
| Classified | 2023-10-26 |
| Reported by FDA | 2023-11-01 |
| Terminated | 2024-08-15 |
| Distributed | Nationwide (US) |
| Quantity | 25,908 iv |
| Reason classes | labeling |
| NDC | 71449-0029-68 |
| Lot numbers | 2330792, 2330801, 2330821, 2330823, 2330825, 2330846, 2330847, 2330856, 2330858, 2330860, 2330866, 2331053 |
| Expiration dates | 2023-10-21, 2023-10-27, 2023-10-28, 2023-11-03, 2023-12-03, 2023-12-17, 2023-12-26, 2023-12-29, 2024-01-13 |
Product
VANCOmycin HCI PF, 1.5 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-029-68.
Reason for recall
Labeling: Not Elsewhere Classified
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0072-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.